Skip to main content
TipRanks
Go Ultimate75% OFF

PharmAla Biotech Holdings, Inc. (MDMA) Cash flow

67 Followers

PharmAla Biotech Holdings, Inc. Cash Flow

TSE:MDMA's free cash flow for Q3 2026 was C$-329.50K. For the 2026 fiscal year, TSE:MDMA's free cash flow was decreased by C$-22.31K and operating cash flow was C$-307.19K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowNov 25Nov 24Nov 23Nov 22Aug 21
C$ -1.04MC$ -321.36KC$ -339.66KC$ -625.37KC$ -173.57K
C$ -935.27KC$ -226.42KC$ -506.74KC$ -994.87KC$ 629.22K
C$ 1.60MC$ 772.12KC$ 189.29KC$ 0.00C$ 2.02M
C$ 40.19KC$ 419.38KC$ 195.04KC$ 852.14KC$ 2.47M
C$ -1.05MC$ -547.78KC$ -846.39KC$ -1.62MC$ -435.76K

Currency in CAD

PharmAla Biotech Holdings, Inc. Cash Flow

-2M-1M01M2M3M20212022202320242025OperatingInvestingFinancing